Solutions in diabetes management and treatment
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to the body's inability to produce or effectively use insulin.
Type 1 diabetes is an autoimmune condition where the pancreas produces little or no insulin, typically appearing in childhood or adolescence, while Type 2 diabetes occurs when cells become resistant to insulin or the pancreas doesn't produce enough insulin, often related to lifestyle factors and more common in adults.
Complications of prolonged hyperglycemia include cardiovascular disease, kidney damage (nephropathy), nerve damage (neuropathy), vision problems (retinopathy), and increased susceptibility to infections, all of which can significantly impact quality of life and reduce life expectancy if not properly managed.
Did you know*?
77 million
Adults with type 2 diabetes in India
25 million
Indians living with prediabetes
> 50%
Population in India unaware of their diabetic status
LongitudinAl Nationwide study on Management And Real-world outComes of diabetes in India (LANDMARC)2
Sanofi’s path-breaking LANDMARC study (a first-of-its-kind, large scale, nationwide, longitudinal, real world study) conducted on patients with Type 2 diabetes found that more than 60% of the patients failed to control sugar over three years despite medication, lifestyle changes, and diet. The research revealed that initially, only 37% of participants had sugar levels that were under control by the end of the study. Neuropathy emerged as the most prevalent complication, affecting 82% of the participants with microvascular complications, while non-lethal myocardial infarction was observed in 40% of the subjects having macrovascular complications.
Saath7: Empowering people living with diabetes since 15+ years
Saath7
Saath7 is Sanofi's flagship Patient Support Program (PSP) designed to revolutionize diabetes management in India. We aim to educate, empower, and support people living with diabetes, helping them achieve better health outcomes. The name represents our core endeavour: working together ('saath' in Hindi) to achieve an HbA1c level under 7.
Comprehensive Support
Our professionally trained counsellors provide personalized guidance to people living with diabetes enrolled by doctors across the country.
Hybrid Approach
We combine regular in-person visits with daily telephonic counselling and innovative virtual
PSP toolkits to ensure continuous support.
Empowering Patients
Saath7 equips people living with diabetes with the tools and knowledge to better manage their diabetes.
Supporting Healthcare Professionals
We assist doctors with high patient loads by providing crucial patient education and follow-up support.
Saath7: Impact by the numbers
50+
• Cities where the program operates
100+
• Counsellors in our team
5000+
• Healthcare professionals supported
100,000
• Patients enrolled every year
Sanofi Diabetes Dialogues
An educational and awareness series in partnership with prominent national and key regional media houses.
Reference
- https://www.who.int/india/health-topics/diabetes accessed on 4 September 2025
- Das AK et al. Endocrinol Diabetes Metab. 2023 Mar;6(2):e404.
MAT-IN-2500816/-v3.0/11-2025